Pharmaceuticals and EDCS in the US water industry - An update

Erin M. Snyder, Richard C. Pleus, Shane A. Snyder

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


The detection of smaller concentrations of some endocrine disrupting chemicals (EDC) and pharmaceuticals in water is discussed. These emerging contaminants appear to be ubiquitous in municipal wastewater treatment plant (WWTP) effluents and in surface waters influenced by effluents, including source waters for drinking water treatment plants. EDCs are agents that interfere with the functioning of natural hormones in the body. Pharmaceuticals found in surface waters include prescription and nonprescription human and veterinary drugs. The US Environmental Protection Agency (USEPA) developed the Endocrine Disruptor Screening Program to identify screening methods and toxicity testing strategies that can be used to identify chemicals as EDC.

Original languageEnglish (US)
Pages (from-to)32-36
Number of pages5
JournalJournal / American Water Works Association
Issue number11
StatePublished - Nov 2005

ASJC Scopus subject areas

  • General Chemistry
  • Water Science and Technology


Dive into the research topics of 'Pharmaceuticals and EDCS in the US water industry - An update'. Together they form a unique fingerprint.

Cite this